Hairy cell leukemia and allied chronic lymphoid leukemias: Current knowledge and new therapeutic options

Leukemia and Lymphoma

Volumn 26, Issue SUPPL. 1, 1997, Pages 41-51

  Polliack, Aaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Chronic lymphoid leukemias; Hairy cell leukemia; Therapy

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; CYTOKINE; FLUDARABINE; INTERLEUKIN 1BETA; INTERLEUKIN RECEPTOR; PENTOSTATIN; PURINE DERIVATIVE; TUMOR NECROSIS FACTOR;

ADVERSE DRUG REACTION; BONE MARROW SUPPRESSION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; FEVER; HAIRY CELL LEUKEMIA; HUMAN; INFECTION; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; RETICULOENDOTHELIAL SYSTEM; SPLENECTOMY; VOMITING;

EID: 0031433048     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709058599     Document Type: Conference Paper

References (66)

1. Bouroncle, B. A., Wiseman, B. K. and Doan, C. A. (1958). Leukemic reticuloendotheliosis. Blood, 13, 609-630.
2. Schrek, R. and Donnely, W. J. (1966). "Hairy Cells" in blood in lymphoreticular neoplastic disease and "flagellated" cells of normal lymph nodes. Blood, 27, 199-211.
3. Bouroncle, B. A. (1979). Leukemic reticuloendotheliosis (Hairy Cell Leukemia). Blood, 53, 412-436.
4. Golomb, H. M., Brayland, R. and Polliack, A. (1975). "Hairy Cell" Leukemia. A scanning electron microscopic study of 8 cases. Brit. J. Haematology, 29, 455-460.
5. Golomb, H. M., Catovsky, D. and Golde, D. W. (1978). Hairy Cell Leukemia. A clinical review based on 71 cases. Annals Internal Medicine, 89, 677-683.
6. Catovsky, D. (1977). Hairy Cell Leukemia and Prolymphocytic Leukemia. Clinics of Hematology, 6, 245-268.
7. Flandrin, G. and Daniel, M. T. (1984). Hairy Cell Leukemia. Cytochemistry und ultrastructure in diagnosis in human leukemias. (ed.) A. Polliack. (Martinus Nijhoff Pub. Klawer, Boston, USA) p. 331-338.
8. Yam, L. T., Li, C. Y. and Lam, K. W. (1971). Tartrate resistant acid phosphatase isoenzyme in leukemic reticuloendotheliosis. New England J. Medicine, 284, 357-360.
9. Katayama, I., Li, C. Y. and Yam, L. T. (1972). Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis. Cancer, 29, 157-164.
10. Katayama, I. and Schneider, G. B. (1977). Further ultrastructural characterization of hairy cells of leukemic reticuloendotheliosis. American Journal of Pathology, 86, 163-174.
11. Bouroncle, B. A. (1987). Unusual presentations and complications of hairy cell leukemia. Leukemia, 1, 288-293.
12. Nanba, K., Soban, E. J., Bowling, M. C. and Berard, C. W. (1977). Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive features of hairy cell leukemia. Am. J. Clin. Pathol., 67, 415-426.
13. Foroni, L., Catovsky, D. and Luzzatto, L. (1987). Immunoglobulin gene rearrangements in hairy cell leukemia and other chronic B cell lymphoproliferative disorders. Leukemia, 4, 389-392.
14. Korsmayer, S. J., Green, W. C., Cossman, J., Hsu, S. M., Jensen, J. P., Neckers, L. M., Marshall, S. L., Bakshsi, A., Depper, J. M., Leonard, W. J., Jaffe, E. S. and Waldmann, T. A. (1983). Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc. Natl. Acad. Sci. USA, 80, 4522-4526.
15. Erber, W. N., Phil, D. and Mason, D. Y. (1988). Expression of the interleukin-2-receptor (Tac antigen/CD25) in hematologic neoplasms. Am. J. Clin. Pathol., 89, 645-648.
16. Falini, B., Pulford, K., Erber, W. N., Posnett, D. N., Pallesen, G., Schwrating, R., Annino, L., Caffolla, A., Canino, S., Mori, A., Minelli, O., Ciani, C., Voxes, E. E., Golomb, H. M., Delsol, G., Stein, H., Martelli, M. F., Grignan, F. and Mason, D. Y. (1986). Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukemia. An immunocytochemical study of 136 cases. Histopathology, 10, 671-687.
17. Posnett, D. N., Chiorazzi, N. and Kunkel, H. G. (1982). Monoclonal antibodies with specificity for hairy cell leukemia cells. J. Clin. Invest., 70, 254-261.
18. Vardiman, J. W., Gilewski, T. A., Ratain, M. J., Bitter, M. A., Bradlow, B. A. and Golomb, H. M. (1988). Evaluation of LeuM5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Am. J. Clin. Pathol., 90, 250-256.
19. Visser, L., Shaw, A., Slupsky, J., Vos, H. and Poppema, S. (1989). Monoclonal antibodies reactive with hairy cell leukemia. Blood, 74, 320-325.
20. Mulligan, S. P., Travade, P., Matutes, E., Dearden, C., Visser, L. and Poppema, S. (1989). Monoclonal antibodies reactive with hairy cell leukemia. Blood, 74, 320-325.
21. Thaler, J., Dietze, O., Faber, V., Greil, R., Gasti, G., Denz, H., Ho, A. D. and Huber, H. (1990). Monoclonal antibody B-ly 7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia. Leukemia, 4, 170-176.
22. Semenzato, G., Trentin, L., Zambello, R., Agostini, C., Bulian, P., Siviero, F., Ambrosetti, A., Vinante, F., Prior, M., Chilosi, M. and Pizzolo, G. (1988). Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia. Leukemia, 2, 788-792.
23. Richards, J. M., Mick, R., Latta, J. M., Daly, K., Ratain, M. J., Vardiman, J. W. and Golomb, H. M. (1990). Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood, 76, 1941-1945.
24. Lauria, F., Rondelli, D., Raspadori, D., Zinzani, P. L., Benefati, D., Pileri, S., Sabattini, E. and Tura, S. (1992). Serum soluble interleukin-2 receptor levels in hairy cell leukemia. Correlation with clinical and hematological parameters and with alpha-interferon therapy. Leukemia and Lymphoma, 7, 103-107.
25. Barak, V., Ginzburg, M., Kalickman, I. and Polliack, A. (1992). Serum soluble IL-2 receptor levels are associated with clinical disease status and grade in lymphoma and CLL. Leukemia and Lymphoma, 7, 431-438.
26. Cimino, G., Annino, L., Giona, F., Sgadari, C., DiGregorio, A. O., Cava, M. C., Cimino, G. and Mandelli, F. (1991). Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia. Leukemia, 5, 602-604.
27. Barak, V., Nisman, B., Kalickman, I., Dann, E. and Polliack, A. (1992). Elevated serum IL-1 levels in Hairy Cell Leukemia and correlation with disease activity. Blood, 80 (10). Supplement, 212 (abstract).
28. Lindemann, A., Ludwig, W. D., Oster, W., Mertelsmann, R. and Hermann, F. (1981). High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood, 73, 880-884.
29. Lauria, F., Raspadori, D., Benfenati, D., Rondelli, D., Pallotti, A. and Tura, S. (1992). Biological markers and minimal residual disease in hairy cell leukemia. Leukemia, 6, 149-151.
30. Flandrin, G., Sigaux, F., Sebanoun, G. and Bouffette, P. (1984). Hairy cell leukemia: clinical presentation and follow-up of 211 patients. Semin. Oncol., 11 (Suppl. 2), 458-471.
31. Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M. and Gutterman, J. U. (1984). Alpha Interferon for from induction of remission in hairy cell leukemia. N. Engl. J. Med., 310, 15-18.
32. Jansen, J. and Hermans, J. (1981). Splenectomy in hairy cell leukemia. A retrospective multicenter analysis. Cancer, 47, 2066-2076.
33. Golomb, H. M., Jacobs, A., Feffer, A., Oker, H., Thompson, J., Portlock, C., Ratain, M., Goldex, D., Vardiman, J., Burke, J. S., Brady, J., Bonnen, E. and Spiegel, R. (1986). Alpha-2 interferon therapy of hairy-cell leukemia: A multicenter study of 64 patients. J. Clin. Oncol., 4, 900-905.
34. Golomb, H. M., Ratain, M. J., Fefer, A., Thompson, J., Golde, D. W., Ozer, H., Portlock, C., Silber, R., Rappeport, J., Bonnen, E., Spiegel, R., Tensen, L., Burke, J. S. and Vardiman, J. W. (1988). Randomized study of the duration of treatment with Interferon alpha-2b in patients with hairy cell leukemia. J. Natl. Cancer Inst., 80, 369-372.
35. Moormeier, J. A., Ratain, M. J., Westbrook, C. A., Vardiman, J. W., Daly, K. M. and Golomb, H. M. (1989). Low-dose interferon alpha-2b in the treatment of hairy cell leukemia. J. Natl. Cancer Inst., 81, 1172-1174.
36. Grever, J., Kopecky, K., Head, D., Cassileth, P., Golomb, H., Haberman, T., Rai, K., Eisenhauer, E and Cheson, B. (1992). A randomized comparison of deoxycoformycin versus alpha-2a interferon in previously untreated patients with hairy cell leukemia: An NCI-sponsored intergroup study (SWOG, ECOG, CALGB, NCl CTG). (Abstract) Proc. Am Soc. Clin. Oncol., 11, 868.
37. Spiers, A. S. D. and Parekh, S. J. (1983). Pentostatin (2′deoxycoformycin, CDF) is active in hairy cell leukemia (Abstract), Blood, 62, 208a.
38. Spiers, A. S. D., Moore, D., Cassileth, P. A., Harrington, D. P., Cummins, F. J., Neiman, R. S., J. M. and O'Connell, M. J. (1987). Remission in hairy cell leukemia with pentostatin (2′-deoxycoformycin). N. Engl. J. Med., 316, 825-830.
39. Cassileth, P. A., Cheuvart, B., Spiers, A. S. D., Harrington, D. P., Cummings, F. I., Neiman, R. S., Bennett, J. M. and O'Connell, M. J. (1991). Pentostatin induces durable remission in hairy cell leukemia. J Clin Oncol., 9, 243-246.
40. Dearden, C. and Catovsky, D. (1990). Treatment of Hairy Cell Leukemia with 2-Deoxycoformycin. Leukemia and Lymphoma, 1, 79-186.
41. Kraut, E. H., Bouroncle, B. A. and Grever, M. R. (1989). Pentostatin in the treatment of advanced hairy cell leukemia. J. Clin. Oncol., 7, 168-172.
42. Saven, A., Piro, L. D., Carrera, C. J., Cardon, D. A. and Beutler, E. (1993). Hairy cell leukemia: New understanding of biology and treatment. Cancer Treat. Res., 64, 15-34.
43. Tallman, M. S., Hakimian, D., Variakojis, D., Koslow, D., Sisney, G. A., Rademaker, A. W., Rose, E. and Kaul, K. (1992). A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood, 80, 2203-2209.
44. Estey, E. H., Kurzrock, R., Kantarjian, M. and O'Brien, S. M., McCredie, K. B., Beran, M., Koller, C., Keating, M. J., Hirsch-Ginsberg, C., Huh, Y. O., Stass, S. and Freireich, E. J. (1992). Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood, 79, 882-887.
45. Juliusson, G. and Liliemark, J. (1992). Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro2′deoxyadenosine (CdA): Relation to opportunistic infections. Blood, 79, 888-894.
46. Juliusson, G., Liliemark, J., Hippe, E., Blichfeldt, P., Walman, K., Hagberg, H., Stolt, C. M., Bergheim, J. L., Winquist, I., Hedenus, M., Carlsson, M., Velin, L., Hellquist, L., Kristofferson, R., Ly, B. E. and Vaart, J. (1992). Subcutaneous injections of 2-chloro1′deoxyadenosine (CdA) as treatment for symptomatic hairy cell leukemia (HCL). (Abstract) Blood, 80 (Suppl. 10), 1427.
47. Liliemark, J., Albertioni, F., Hassan, M. and Juliusson, G. (1992). On the bioavailability of oral and subcutaneous 2′-chloro-′deoxyadenosine in humans: alternative routes of administration. J Clin Oncol., 10, 1514-1518.
48. Mintz, U. and Golomb, H. M. (1979). Splenectomy as initial therapy in 26 patients with hairy cell leukemia. Cancer Research, 39, 2366-2370.
49. Saven, A. and Piro, L. D. (1993). 2-CdA in the treatment of Hairy Cell Leukemia and Chronic Lymphocytic Leukemia. Leukemia and Lymphoma, 11 (Supp 2), 109-114.
50. Saven, A. and Piro, L. D. (1992). Treatment of Hairy Cell Leukemia. Blood, 79, 1111-1120.
51. Robbins, B. A., Ellison, D. J., Spinosa, J. C., Carry, C. A., Lukes, R. J., Poppema, S., Saven, A. and Piro, L. D. (1993). Diagnostic application of 2-color flow cytometry in 161 cases of hairy cell leukemia. Blood, 82, 1277-1287.
52. Cheson, B. D. (1993). Purine analogs in lymphoproliferative disorders. Leukemia and Lymphoma, II (Suppl 2), 153-160.
53. Pangalis, G. A., Boussiotis, V. A., Kittas, C., Panayiotidis, P. A., Loukopoulus. D. and Fessas, P. (1991). Hairy cell leukemia: Splenectomy after alpha 2b-interferon therapy. Blood, 78, 1385.
54. Thaler, J., Grünewald, K., Gattringer, C., Ho, A. D., Weyrer, K., Dieze, O., Stauder, R., Fluckinger, T., Lang, A. and Huber, H. (1993). Long term follow-up of patients with hairy cell leukemia treated with pentostain. Lymphocytic subpopulations and residual bone marrow infiltration. British Journal of Haematology, 84, 75-82.
55. Hakimian, D., Tallman, M. S., Kiley, C. and Peterson, L. (1993). Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-CdA for hairy cell leukemia. Blood, 82, 1798-1802.
56. Beutler, E., Piro, L. D., Saven, A., Kay, A. C., et al. (1991). 2-CdA: A potent chemotherapeutic and immunosuppressive nucleoside. Leukemia and Lymphoma, 5, 1-10.
57. Ratain, M., Golomb, H. M., Vardiman, J. W., Westbrook, C. A., Barker, C., Hooberman, A., Bitter, M. A. and Daly, K. (1988). Relapse after Interferon alfa-2B therapy for Hairy Cell Leukemia. Analysis of prognostic variables. J. Clinical Oncology, 6, 1714.
58. Bennett, J. M., Catovsky, D., Daniel, M. T. et al. (1989). Proposals for the classification of chronic (mature) B and T lymphoid leukeias. J. Clinical Pathology, 42, 567-584.
59. Galton, D. A. G., Goldman, J. M., Wiltshaw, J. M. et al. (1974). Prolymphocytic Leukemia. British Journal of Haematology, 27, 7-23.
60. Cawley, J. C., Burns, G. F. and Hayhoe, R. G. H. (1980). A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy cell leukemia. Leukemia Research, 4, 547-559.
61. Catovsky, D., O'Brien, M., Melo, J. V. et al. (1984). Hairy Cell Leukemia (HCL) variant. An intermediate disease between HCL and B-prolymphocytic leukemia. Seminars Oncology, 11, 362-369.
62. Melo, J. V., Hedge, U., Parreira, A. et al. (1987). Splenic B-cell lymphoma with circulating villous lymphocytes: differential diagnosis of B-cell leukemias with large spleens. J. Clinical Pathology, 40, 642-651.
63. Neiman, R. S., Sullivan, A. L. and Jaffe, R. (1979). Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of 10 cases. Cancer, 43, 329-342.
64. Jaffe, S., Bookman, M. A. and Longo, D. L. (1987). Lymphocytic lymphoma of intermediate differentiation. Mantle zone lymphoma: a distinct subtype of B-cell lymphoma. Human Pathology, 18, 877-880.
65. Mulligan, S. P. and Catovsky, D. (1992). Splenic lymphoma with villous lymphocytes. Leukemia & Lymphoma, 6, 97-106.
66. Sainati, L., Matutes, E., Mulligan, S. et al (1990). A variant form of hairy cell leukemia resistant to interferon. Blood, 76, 157-162.